Hyperthecosis

Hyperthecosis
Classification and external resources
Specialty endocrinology
ICD-10 E28.8
ICD-9-CM 256.8

Hyperthecosis (or ovarian hyperthecosis) is hyperplasia of the theca interna of the ovary.[1] Hyperthecosis occurs when an area of luteinization occurs along with stromal hyperplasia. The luteinized cells produce androgens, which may lead to hirsutism and virilization (or masculinization) in affected women.[2]

The term hyperthecosis refers to the presence of nests of luteinized theca cells in the ovarian stroma due to differentiation of the ovarian interstitial cells into steroidogenically active luteinized stromal cells. These nests or islands of luteinized theca cells are scattered throughout the stroma of the ovary, rather than being confined to areas around cystic follicles as in polycystic ovary syndrome (PCOS). These luteinized theca cells result is greater production of androgens.

Seen as a severe form of PCOS, the clinical features of hyperthecosis are similar to those of PCOS.[3] Women with hyperthecosis often have more markedly elevated testosterone, more hirsutism, and are much more likely to be virilized.[4] While elevated androgens in postmenopausal women is rare,[5] hyperthecosis can present in both premenopausal or postmenopausal women. Women with hyperthecosis may or may not have always had underlying PCOS.[6]

Cause

The etiology of hyperthecosis is unknown, however evidence suggests a possibility of genetic transmission. Hyperthecosis has been documented in familiar patterns.[7] Insulin resistance may also play a role in the pathogenesis of hyperthecosis. Women with hyperthecosis have a significant degree of insulin resistance and insulin may stimulate the ovarian stromal androgen synthesis.[8]

Prognosis

Although no large studies showing the long term outcomes for women with hyperthecosis exist, a diagnosis of hyperthecosis may suggest an increased risk for metabolic complications of hyperlipidemia and type 2 diabetes .[9] In postmenopausal women, hyperthecosis may also contribute to the pathogenesis of endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma due to the association of hyperestrinism (excess estrins in the body) and hyperthecosis.[10] Treatment for hyperthecosis is based upon each case, but may range from pharmacological interventions to surgical.[11]

See also

References

  1. ↑ Taber's Cyclopedic Medical Dictionary 21st Edition
  2. ↑ Stead, Stead, Kaufman, Suarez (2009). First Aid for the Obstretrics & Gynecology Clerkship - Second Edition. McGraw-Hill
  3. ↑ Zhang, Cunxian; Sung, C. James; Quddus, M. Ruhul; Simon, Rochelle A.; Jazaerly, Tarek; Lawrence, W. Dwayne (2017-01-01). "Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases". Human Pathology. 59: 120–124. doi:10.1016/j.humpath.2016.09.021.
  4. ↑ http://www.uptodate.com/contents/ovarian-hyperthecosis
  5. ↑ Krug, Esther; Berga, Sarah L. (2002-01-01). "Postmenopausal hyperthecosis: Functional dysregulation of androgenesis in climacteric ovary". Obstetrics and Gynecology. 99 (5 SUPPL. 1). ISSN 0029-7844. doi:10.1016/S0029-7844(01)01588-5.
  6. ↑ Wierman, MD, Margaret (2016). "Polycystic Ovarian Syndrome : 2016 Meet-The-Professor: Endocrine Case Management". doi:10.1210/mtp5.9781943550043.ch57. Retrieved 2017-05-03.
  7. ↑ Wilroy, R.S. (February 1975). "Hyperthecosis: an inheritable form of polycystic ovarian disease". ResearchGate. Retrieved 2017-05-03.
  8. ↑ Nagamani M.D., Manubai (February 1986). "Hyperinsulinemia in hyperthecosis of the ovaries - ScienceDirect". www.sciencedirect.com. Retrieved 2017-05-03.
  9. ↑ Rothman, Micol S.; Wierman, Margaret E. (2011-08-01). "How should postmenopausal androgen excess be evaluated?". Clinical Endocrinology. 75 (2): 160–164. ISSN 1365-2265. doi:10.1111/j.1365-2265.2011.04040.x.
  10. ↑ Zhang, Cunxian; Sung, C. James; Quddus, M. Ruhul; Simon, Rochelle A.; Jazaerly, Tarek; Lawrence, W. Dwayne (2017-01-01). "Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases". Human Pathology. 59: 120–124. ISSN 0046-8177. doi:10.1016/j.humpath.2016.09.021.
  11. ↑ Krug, Esther; Berga, Sarah L. (2002-01-01). "Postmenopausal hyperthecosis: Functional dysregulation of androgenesis in climacteric ovary". Obstetrics and Gynecology. 99 (5 SUPPL. 1). ISSN 0029-7844. doi:10.1016/S0029-7844(01)01588-5.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.